Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

49
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
49
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

83
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
83
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

609
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
609
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

36
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
36
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

103
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
103
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

64
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
64

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abaloparatide increases bone mass by increasing bone formation regardless of alendronate pretreatment in mice.

Journal of oral biosciences·2026
Same author

Fraction-based Linear Extrapolation (FLEX) Method for Predicting Human Pharmacokinetic Clearance: Advanced Allometric Scaling Method and Machine Learning Approach.

Pharmaceutical research·2025
Same author

Computational approaches to DMPK: A realistic assessment of current methods and their practical impact. Part I: Physicochemical and in vitro properties.

Drug discovery today·2025
Same author

Machine Learning Prediction and Validation of Plasma Concentration-Time Profiles.

Molecular pharmaceutics·2025
Same author

An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with renal dysfunction.

Pharmacology research & perspectives·2024
Same author

Prediction of Inhibitory Activity against the MATE1 Transporter via Combined Fingerprint- and Physics-Based Machine Learning Models.

Journal of chemical information and modeling·2024

Related Experiment Video

Updated: Jun 12, 2025

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
13:34

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Published on: April 16, 2019

9.1K

A Practical In Silico Method for Predicting Compound Brain Concentration-Time Profiles: Combination of PK Modeling

Koichi Handa1, Daichi Fujita1, Mariko Hirano1

  • 1Toxicology & DMPK Research Department, Teijin Institute for Bio-medical Research, Teijin Pharma Limited, 4-3-2 Asahigaoka, Hino-shi, Tokyo 191-8512, Japan.

Molecular Pharmaceutics
|September 26, 2024
PubMed
Summary

Developing a new in silico method combining modeling and simulation with machine learning to predict drug concentrations in the brain. This approach reduces the need for extensive animal testing, offering a more efficient way to study central nervous system drugs.

Keywords:
CNSPK parametersQSARcompound brain concentration−time profilescompound designmachine learningmodeling and simulationmouse pharmacokineticsrandom forest

More Related Videos

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.5K
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.2K

Related Experiment Videos

Last Updated: Jun 12, 2025

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
13:34

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Published on: April 16, 2019

9.1K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.5K
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.2K

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Computational Drug Discovery
  • Neuroscience

Background:

  • Aging global populations drive demand for new central nervous system (CNS) drugs.
  • The blood-brain barrier poses a significant challenge for CNS drug delivery.
  • Current methods for assessing drug distribution in the brain are often costly, time-consuming, and require extensive animal studies.

Purpose of the Study:

  • To develop an in silico prediction method for brain drug concentrations.
  • To reduce the experimental data and animal usage required for CNS drug development.
  • To integrate modeling and simulation (M&S) with machine learning (ML) for enhanced prediction accuracy.

Main Methods:

  • A hybrid model was constructed to link plasma concentration-time profiles to brain compartment dynamics, accounting for transit time and distribution.
  • Machine learning models were built using chemical structure descriptors to predict kinetic parameters.
  • Three scenarios were evaluated: Scenario I (full brain concentration-time data), Scenario II (ML predictions fed into the hybrid model), and Scenario III (parameter refitting using a single time point).

Main Results:

  • Scenario II achieved RMSE/R2 values of 0.445/0.517 for predicting brain compound concentration-time profiles.
  • Scenario III, using a single time point, significantly improved prediction accuracy with RMSE/R2 values of 0.246/0.805.
  • The developed method demonstrates high accuracy and practicality for predicting brain compound concentration-time profiles.

Conclusions:

  • The combined M&S and ML approach offers a powerful tool for predicting CNS drug pharmacokinetics.
  • The method significantly reduces the need for extensive experimental data and animal testing.
  • This in silico strategy provides a practical and accurate solution for CNS drug discovery and development.